文献速递神经介入DSA

血管内取栓术与标准药物治疗在急性中等血管闭塞性卒中治疗中的比较:一项多中心登记研究

Endovascular Thrombectomy versus Standard Medical Management in Treatment of Acute Medium Vessel Occlusion Strokes: A Multicenter Registry.
PubMed 文献 · Radiology · 2025-01-01

这项多中心回顾性研究纳入25个卒中中心2019年9月至2024年9月的1075例急性中等血管闭塞卒中患者,比较血管内取栓术与标准药物治疗。取栓术组90天改良Rankin量表评分分布改善(调整共同OR 1.38,95%CI 1.18-1.61,P<.001),无症状性颅内出血或90天死亡率增加。亚组分析显示NIHSS≥6分患者获益,而NIHSS 1-5分患者未获益。

要点

  • 中等血管闭塞急性卒中取栓术与标准药物治疗相比,90天mRS评分分布更优(调整共同OR 1.38)。
  • 取栓术组90天mRS 0-1分比例43.7% vs 标准治疗组36.1%,调整RR 1.61。
  • 取栓术组与标准治疗组90天死亡率和症状性颅内出血率无显著差异。

核心结论

  • 与标准药物治疗相比,血管内取栓术与急性中等血管闭塞卒中患者更好的结局相关,尤其是症状更严重的患者,且不增加症状性颅内出血或90天死亡率。

研究设计与样本

  • 多中心回顾性研究,纳入25个卒中中心2019年9月至2024年9月的1075例急性缺血性卒中患者(大脑中动脉M3或M4段、大脑前动脉或大脑后动脉闭塞),取栓术组529例,标准药物治疗组546例;主要终点为90天mRS评分的序贯移位。

诊断标准与关键数值

  • 主要分析采用逆概率治疗加权,90天mRS分布改善(调整共同OR 1.38;95%CI 1.18,1.61;P<.001) favoring EVT;mRS 0-1分率取栓术组43.7%(231/529)vs 标准治疗组36.1%(197/546),调整RR 1.61(95%CI 1.33,1.96;P<.001);mRS 0-2分率取栓术组60.9%(322/529)vs 标准治疗组53.5%(292/546),调整RR 1.39(95%CI 1.14,1.69;P=.001)。

临床应用与阅片要点

  • 亚组分析显示,NIHSS评分≥6分患者取栓术获益(调整RR 1.62;95%CI 1.37,1.92),而NIHSS评分1-5分患者未获益(调整RR 0.79;95%CI 0.58,1.19;交互作用P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Randomized trials have shown that endovascular thrombectomy (EVT) benefits patients with large vessel occlusion; however, its role in medium vessel occlusion remains unclear. Purpose To compare the efficacy and safety of EVT versus standard medical management in medium vessel occlusion stroke. Materials and Methods This multicenter, retrospective study enrolled patients with acute ischemic stroke from an occlusion of M3 or M4 segments of the middle cerebral artery, anterior cerebral artery, or posterior cerebral artery from 25 stroke centers (September 2019 to September 2024). The primary end point was an ordinal shift in 90-day modified Rankin Scale (mRS) scores. Safety outcomes included 90-day mortality and symptomatic intracranial hemorrhage at 24 hours. Results A total of 1075 patients were included in the study (median age, 69 years; IQR, 59-76 years; 637 men; 529 treated with EVT and 546 treated with standard medical management; median baseline National Institutes of Health Stroke Scale [NIHSS], 10 [IQR, 6-12]). In the primary analysis using inverse probability of treatment weighting, there was an improvement in 90-day mRS distribution (adjusted common odds ratio, 1.38; 95% CI: 1.18, 1.61; P < .001) favoring EVT. Rates of mRS scores of 0-1 (43.7% [231 of 529 patients] vs 36.1% [197 of 546 patients]; adjusted risk ratio [RR], 1.61; 95% CI: 1.33, 1.96; P < .001) and mRS scores of 0-2 (60.9% [322 of 529 patients] vs 53.5% [292 of 546 patients]; adjusted RR, 1.39; 95% CI: 1.14, 1.69; P = .001) were higher with EVT. Between EVT and standard medical management groups, there was no difference in 90-day mortality (8.32% [44 of 529 patients] vs 8.97% [49 of 546 patients]; adjusted RR, 0.74; 95% CI: 0.51, 1.12; P = .17) or symptomatic intracranial hemorrhage (11.5% [61 of 529 patients] vs 10.4% [57 of 546 patients]; adjusted RR, 1.24; 95% CI: 0.92, 1.66; P = .16). Subgroup analyses indicated EVT benefit in patients with an NIHSS score of 6 or higher (adjusted RR, 1.62; 95% CI: 1.37, 1.92), but not in those with an NIHSS score of 1-5 (adjusted RR, 0.79; 95% CI: 0.58, 1.19; P value for interaction < .001). Conclusion Compared with standard medical management, EVT was associated with better outcomes in patients with acute medium vessel occlusion stroke, particularly those with more severe symptoms, without increasing symptomatic intracranial hemorrhage or 90-day mortality. Chinese Clinical Trial Registry no. ChiCTR2500096954 © The Author(s) 2025. Published by the Radiological Society of North America under a CC BY 4.0 license. Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Jing X, Chen Z, Zhao Y, et al. Endovascular Thrombectomy versus Standard Medical Management in Treatment of Acute Medium Vessel Occlusion Strokes: A Multicenter Registry. Radiology. 2025. PMID: 41288486. doi:10.1148/radiol.251040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。